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Abstract: The objective of the study was to ascertain whether human health beneficial omega–3
long-chain (≥C20) polyunsaturated fatty acid (n-3 LC-PUFA) content in heart, kidney and liver can be
enhanced by supplementing prime lambs with graded levels of canola and flaxseed oil. Health status
of the lambs, as a consequence of the supplementation, was also investigated by examining their
plasma metabolites. Sixty purebred and first-cross lambs were allocated to one of five treatments of
lucerne hay basal diet supplemented with isocaloric and isonitrogenous wheat-based pellets without
oil inclusion (Control) or graded levels of canola oil at 2.5% (2.5C), 5% (5C), flaxseed oil at 2.5%
(2.5F) and 5% (5F) in a completely randomised design. Pre-slaughter blood, post-slaughter kidney,
liver and heart samples were analysed for plasma metabolite and fatty acid profiles. Summations
of docosapentaenoic acid and docosahexaenoic acid, and total n-3 LC-PUFA were enhanced in
the liver and kidney of 5F supplemented lambs with a marked decrease in n-6/n-3 ratio and
significant breed differences detected. There were generally no deleterious impacts on animal
health status. A combination of 5% oil supplementation and lamb genetics is an effective and
strategic management tool for enhancing n-3 LC-PUFA contents of heart, kidney and liver without
compromising lamb health.
Keywords: prime lamb; oil supplementation; visceral organs; n-3 LC-PUFA; plasma metabolites
1. Introduction
The Australian Guide to Healthy Eating and Australian Dietary Guidelines [1] promote health and
wellbeing by providing scientific evidence based dietary advice to reduce the risk of high cholesterol,
high blood pressure, obesity, type 2 diabetes, cardiovascular disease and cancers. Therefore, consumers
have become more aware and concerned about the relationship between dietary intake and health
as their health consciousness increases. High levels of saturated fatty acids (SFA) and low content
of polyunsaturated fatty acids (PUFA) in red meat have been implicated in the increased incidence
of chronic diseases, especially cardiovascular diseases, diabetes and cancers [2,3]. Enser et al. [4]
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reported that lamb contains a higher fat percentage than beef and pork, and lower levels of PUFA in
comparison with pork. Therefore, reducing fat content and modifying the fatty acid profile of lamb
edible products have been warranted [5] and received much attention (see reviews by De Brito et al. [6]
and Alvarenga et al. [7]).
The main way of improving the PUFA content in ruminants is the supplementation of PUFA
enriched plant oils in their diets [8,9]. Canola and flaxseed oils, which contain an abundance of
α-linoleic acid (ALA, 18:3n-3) [10,11], have been of recent interest in numerous nutritional trials
in order to mainly improve n-3 LC-PUFA contents including eicosapentaenoic acid (EPA, 20:5n-3),
docosapentaenoic acid (DPA, 22:5n-3) and docosahexaenoic acid (DHA, 22:6n-3) in sheep meat [12–15].
Genetic management of livestock for enhancing n-3 LC-PUFA content through selective breeding
provides an alternative to nutritional manipulation and it is a cumulative and long-term approach.
Several studies have been undertaken to investigate the impacts of different breeds on fatty acid
profiles [16–18]. However, these investigations were only limited to the effect of breed on muscle
fatty acid composition. In many countries, the consumption of non-carcass components, for instance
heart, liver and kidney is very common. Furthermore, offal such as various organs can be a cheap
source of proteins, minerals and vitamins [19,20] and play an important role in processed product
formulations [20]. Liver and kidney are typically used in processed food products, such as pies and
pasties which may not necessarily be healthy. Thus, lamb edible products include not only meat,
but also these visceral organs. Meat and Livestock Australia (MLA) can strategically promote and
encourage the direct intake and export of such offal organs instead of processed “junk food” if there
were science-based empirical data suggesting that these offal organs contained health-claimable levels
of n-3 LC–PUFA. The effects of different lipid sources and supplemented levels on altering the fatty acid
profiles of liver and kidney in cattle and goat have been documented [5,21]. Kim et al. [22] also reported
the variations in fatty acid composition in liver of Katadhin Dorper lambs fed 4.0% oil supplements
with different n-6/n-3 fatty acid ratio. Nonetheless, studies investigating fatty acid profiles of heart,
liver and kidney in prime lambs influenced by both dietary canola and flaxseed oil supplementation
and breed are scanty and have not been undertaken under pasture-based production system.
Knowledge of haematological metabolite concentrations is valuable in understanding the
individual health status and productivity of lambs [23]. Hence, quantifying the changes in plasma
metabolite concentrations in lambs due to feed supplements and genetics is essential [24], especially
the plasma metabolite profiles of prime lambs supplemented with graded levels of canola and flaxseed
oil. The primary objective of this study was to investigate the effects of graded levels of canola and
flaxseed oil supplementation to purebred Merino and first-cross prime lambs on heart, liver and kidney
fatty acid profiles, including absolute contents, and the plasma metabolites. The secondary aim was to
evaluate the interactions of supplementation level with breed.
2. Materials and Methods
2.1. Location and Animals
This research was conducted at the Cressy Research and Demonstration Station, Cressy, Tasmania,
Australia, between June and August 2014. The experimental design and procedures were approved
by the University of Tasmania Animal Ethics Committee (Permit No. A13839). The study was also in
accordance with the 1993 Tasmania Animal Welfare Act and the 2013 Australian Code of Practice for
the Care and Use of Animals for Scientific Purposes.
Sixty weaned ewe (n = 30) and wether (n = 30) prime lambs (seven months of age, mean 33.4 kg
liveweight) were used in this feeding trial. The lambs comprised 20 purebred Merinos (M × M),
20 Corriedale ×Merino (C ×M) and 20 White Suffolk × Corriedale (W × C) first-cross lambs with
equal number of ewe and wether lambs represented in each breed.
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2.2. Experimental Design and Diets
A completely randomised experimental design balanced by breed and sex was utilised. Lambs
were supplemented daily with 1 kg of isocaloric and isonitrogenous wheat-based pellets and allocated
to one of five treatments of 12 lambs per group: no oil inclusion (Control); 2.5% canola oil (2.5C);
5% canola oil (5C); 2.5% flaxseed oil (2.5F) and 5% flaxseed oil (5F) on dry matter basis for 7 weeks
after a three-week adaptation period. Lambs had ad libitum access to the basal diet of lucerne hay and
clean water. Residual feed leftover was removed and weighed prior to fresh feed being offered to
experimental lambs at 0900 h.
2.3. Blood and Visceral Organ Sampling
At the end of the feeding trial, blood samples were collected using jugular venipuncture.
The lambs were organised for blood sample collection in the cool hours of the morning. Individual
lambs within each treatment group were gently restrained in a relaxed sitting position with one
researcher holding their heads ensuring they were comfortably upright and stable on flat ground
to minimise individual animal variation and stress. These were stored in tubes containing heparin,
immediately chilled in an esky containing ice and later centrifuged at 3000 rpm for 20 min at 4 ◦C.
Plasma sub-samples were taken and stored at −20 ◦C for subsequent laboratory analysis.
After collecting blood samples, the lambs were walked to an adjacent commercial abattoir (100 m)
and fasted overnight with water available in lairage. They were slaughtered the next day following
Meat Standards Australia regulations. Heart, kidney and liver samples were taken immediately
after evisceration. All samples were vacuum-sealed, code-labelled and stored at −20 ◦C until fatty
acid analysis.
2.4. Feed Chemical Analysis
Concentrate pellet and lucerne hay samples were collected on days 0, 25 and 49 of the experimental
period and kept at −20 ◦C for subsequent analyses. At the end of the experiment, the samples were
defrosted; the three replicates for each sampling day were pooled and ground through a 1 mm screen.
Samples were dried in triplicates in a fan-forced oven to a constant weight at 65 ◦C to determine
dry matter (DM) content. Total Nitrogen (N) was quantified using an elemental analyser (PE2400
Series II; Perkin-Elmer Corp, Waltham, MA, USA), and multiplied by 6.25 to estimate crude protein
(CP) content. Ether extract (EE) was determined using an ANKOM fat/oil extractor (ANKOMXT15;
ANKOM Technology, Macedon, NY, USA). Acid detergent fibre (ADF) and neutral detergent fibre
(NDF) contents were measured using an ANKOM fibre analyser (ANKOM220; ANKOM Technology,
Macedon, NY, USA). Ash content was quantified by combusting the samples in a furnace at 550 ◦C for
5 h. Organic matter (OM) was computed as OM = 100 − Ash. Non-fibrous carbohydrates (NFC) was
calculated as NFC = 100 − (CP + NDF + EE + Ash) [25]. Metabolisable energy (ME) was estimated
using a near infrared reflectance spectroscopy method [26].
2.5. Fatty Acid and Plasma Metabolite Analyses
The total lipid extraction and fatty acid (FA) profile analysis of feed and visceral samples
were undertaken at the Commonwealth Scientific and Industrial Research Organization (CSIRO),
Oceans & Atmosphere, Hobart, Tasmania, Australia. The procedures were outlined in detail by
Malau-Aduli et al. [27]. In brief, total lipids in 1 g of samples were solvent extracted using a modified
Bligh and Dyer [28] protocol. CH2Cl2:MeOH:Milli-Q H2O (1:2:0.8 v/v) was used in a single-phase
overnight process to extract lipids, followed by phase separation with CH2Cl2:saline Milli-Q H2O
(1:1 v/v), and then rotary evaporated at 40 ◦C to obtain total lipids.
Aliquots of the total lipid extracts were methylated in methanol:dichloromethane
(DCM):concentrated hydrochloric acid (10:1:1 v/v) for 2 h at 80 ◦C to produce fatty acid methyl
esters (FAME). Glass test tubes fitted with Teflon-line screw caps (Brandon Scientific Glassblowing,
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Margate, TAS, Australia) were cooled and 1 mL of Milli-Q® water added, along with 1.8 mL hexane:
DCM (4:1 v/v). Tubes were vortexed and centrifuged at 2000 rpm for 5 min to break phase, with
the upper, organic layer removed. This extraction step was repeated twice. The organic layer was
reduced under a stream of nitrogen gas. DCM, with 0.1 mL of internal injection standard (19:0 FAME)
was added. A 7890B gas chromatograph (GC) (Agilent Technologies, Palo Alto, CA, USA) equipped
with an Equity™-1 fused silica capillary column (50 m × 0.32 mm internal diameter and 0.1-µm film
thickness) (Supelco, Bellefonte, PA, USA), a flame ionisation detector, a split/splitless injector (Agilent
Technologies, Palo Alto, CA, USA), and an Agilent Technologies 7683 B series autosampler was used
to analyse the FAME samples. Fatty acid peaks were quantified by ChemStation software (Agilent
Technologies, Palo Alto, CA, USA). GC-mass spectrometry (GC/MS) analyses were undertaken of
selected samples to confirm FA identities and was performed using a Thermo Scientific 1310 GC
coupled with a TSQ triple quadrupole (Thermo-Fisher Scientific, Milan, Italy). Samples were injected
using a Tripleplus RSH auto sampler with a non-polar HP-5 Ultra 2 bonded–phase column (50 m ×
0.32 mm i.d. × 0.17 µm film thickness; Agilent Technologies, Palo Alto, CA, USA). The HP-5 column
was of similar polarity to the column used for GC analyses. The initial oven temperature of 45 ◦C was
held for 1 min, followed by temperature programming at 30 ◦C per min to 140 ◦C then at 3 ◦C per
min to 310 ◦C where it was held for 12 min. Helium was used as the carrier gas. Mass spectrometer
operating conditions were: electron impact energy 70 eV; emission current 250 µA, transfer line 310 ◦C;
source temperature 240 ◦C; scan rate 0.8 scan/sec and mass range 40–650 Da. Mass spectra were
acquired and processed with Thermo Scientific XcaliburTM software (Waltham, MA, USA).
Fatty acid profiles comprised percentage (g/100 g of total FA (TFA) or %TFA) and content
(mg/100 g of wet tissue). Fatty acid percentages were qualitatively calculated from FA area output:
FA% = (area of individual FA) × (100)/(total FA area). Fatty acid content was computed as FA
(mg/100 g) = (Total lipid percentage) × 0.916 × ((FA%)/100) × 1000 [29], with 0.916 as a lipid
conversion factor [30] as cited by Clayton [29].
Plasma sub-samples were analysed for metabolite concentrations at the Animal Health Laboratory
of the Tasmanian Department of Primary Industries, Parks, Water and Environment (DPIPWE),
Launceston, Tasmania, Australia. Cholesterol, urea, calcium, magnesium, beta-hydroxybutyrate
(BHB) and glucose were analysed on a Konelab 20XTi Clinical Chemistry Analyser (Thermo Scientific,
Waltham, MA, USA).
2.6. Statistical Analysis
All data were analysed using Statistical Analysis System (SAS 2014, SAS Institute, Cary, NC,
USA). Summary statistics including means and standard errors were computed and scrutinised for any
erroneous data entry prior to running an analysis of variance (ANOVA). Since lambs were repeatedly
weighed every week to compute average daily gains; feed samples taken on days 0, 25 and 49 of the
experimental period and offal analysis was based on three replicates per organ, the need for a repeated
measures analysis of variance model was warranted. The data were fitted into a repeated measures
general linear model (PROC GLM) with oil supplementation, lamb breed, and their interaction as
fixed effects, and total lipid percentages, FA profiles and plasma metabolites as dependent variables.
Significant differences and mean separations at the p < 0.05 threshold were performed using Tukey′s
probability pairwise comparison tests.
3. Results
3.1. Feed Ingredients, Chemical Compositions and Fatty Acid Profiles
The ingredients, chemical compositions and fatty acid profiles of the experimental pellets and
lucerne hay are given in Table 1. The major carrier ingredient in the pellets was wheat (465–551 g/kg).
The DM, CP, EE and ME contents, and other chemical compositions were relatively similar among the
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five treatment pellets. Lucerne hay had higher CP, NDF, ADF contents, and lower EE and ME contents
than the pellets.
The prominent unsaturated fatty acids in pellets were 18:2n-6 and 18:1n-9, while 18:2n-6 and
18:3n-3 were the highest unsaturated fatty acids in lucerne hay. The control pellets had higher PUFA
composition (48.4 g/100 g FA), but lower PUFA/SFA and n-6/n-3 ratios (2.0 and 11 respectively)
compared to the oil supplemented pellets. Lucerne hay had low PUFA/SFA and n-6/n-3 ratios (0.9).
EPA, DHA and DPA were not detected in the pellets and lucerne hay.
Table 1. Ingredients, chemical compositions and fatty acid percentage of feeds.
Item
Pellet Feed 1
Lucerne Hay
Control 2.5C 5C 2.5F 5F
Ingredients (g/kg)
Wheat 513 537 545 551 465 -
Paddy rice 260 230 210 220 280 -
Lupins 170 151 138 147 148 -
Canola oil (mL/kg) - 25 50 - - -
Flaxseed oil (mL/kg) - - - 25 50 -
Salt 10 10 10 10 10 -
Limestone 21 21 21 21 21 -
Sheep premix 1 1 1 1 1 -
Ammonium sulfate 12.6 12.6 12.6 12.6 12.6 -
Acid buff 6.2 6.2 6.2 6.2 6.2 -
Sodium bicarbonate 6.2 6.2 6.2 6.2 6.2 -
Chemical compositions (% dry matter) 2
Dry matter, (%) 89.8 90.2 87.9 90.5 89.4 89.6
Crude protein 14.7 14.5 14.4 14.5 14.5 17.4
NDF 23.8 23.5 23.9 23.7 23.3 46.5
ADF 9.2 9.3 8.9 9.5 9.0 30.9
NFC 50.5 49.9 47.8 50.5 50.7 27.4
Ether extract 3.0 4.6 5.7 4.2 5.1 2.4
Ash 8.0 7.5 8.2 7.1 6.4 7.2
ME (MJ/kgDM) 10.7 10.9 11.1 10.8 11.1 9.8
Fatty acid percentage (g/100 g total FA) 3
14:0 0.2 0.5 0.6 0.2 0.2 0.6
15:0 0.1 0.1 0.1 0.1 0.1 0.4
16:0 18.2 16.9 16.5 19.1 19.8 29.6
17:0 0.1 0.1 0.2 0.1 0.1 0.7
18:2n-6 43.4 28.4 26.7 25.6 24.7 19.1
18:3n-3 3.5 3.6 4.3 4.9 7.2 18.8
18:1n-9 23.9 38.9 37.5 32.3 34.1 5.6
18:0 3.4 4.1 4.1 4.4 5.1 4.7
20:3n-6 0.3 0.4 0.4 0.4 0.5 0.4
20:4n-3 0.4 0.5 0.2 0.5 0.6 0.5
20:2n-6 0.1 0.1 0.2 0.1 0.1 0.1
20:0 0.5 0.8 0.7 0.7 0.8 1.5
∑SFA 24.1 23.0 25.0 26.7 28.7 47.3
∑MUFA 27.5 42.6 43.3 36.3 37.5 12.7
∑PUFA 48.4 34.4 31.7 37.0 33.8 40.0
PUFA/SFA 2.0 1.5 1.3 1.4 1.2 0.9
∑n-3 PUFA 3.9 4.1 4.8 5.5 7.9 20.5
∑n-6 PUFA 43.8 28.8 27.4 26 25.3 19.4
n-6/n-3 11.1 7.0 5.7 4.7 3.2 0.9
1 2.5C: 2.5% canola oil; 5C: 5% canola oil; 2.5F: 2.5% flaxseed oil; 5F: 5% flaxseed oil; ADF: acid detergent fibre;
MJ: mega joules; DM: dry matter. 2 NFC: non-fibrous carbohydrates (NFC = 100 − (crude protein (CP) + neutral
detergent fibre (NDF) +ether extract (EE) + ash)); ME: metabolisable energy. 3 ∑SFA: total saturated fatty acid
includes: 14:0, 15:0, 16:0, 17:0, 18:0, 20:0, 21:0, 22:0, 23:0, 24:0; ∑MUFA: total monounsaturated fatty acid includes:
14:1, 16:1n-9, 16:1n-7, 16:1n-5, 16:1n-13, 17:1n-8 + a17:0, 17:1, 18:1n-9, 18:1n-7, 18:1, 19:1, 20:1n-11, 20:1n-9, 20:1n-7,
20:1n-5, 22:1n-9, 22:1n-11, 22:1n-9, 24:1n-9; ∑PUFA: total polyunsaturated fatty acid includes: 18:3n-6, 18:2n-6,
18:3n-3, 20:4n-3, 20:4n-6, 20:5n-3, 20:3n-6, 20:2n-6, 22:5n-6, 22:6n-3, 22:5n-3, 22:4n-6, 24:6n-3, 24:5n-3; ∑n-3 PUFA:
total omega–3 PUFA includes 18:3n-3, 20:5n-3, 20:4n-3, 22:6n-3, 22:5n-3; ∑n-6 PUFA: total omega–6 PUFA includes
18:3n-6, 18:2n-6, 20:4n-6, 20:3n-6, 20:2n-6, 22:5n-6, 22:4n-6.
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3.2. Heart Fatty Acid Profile
The inclusion of 5% flaxseed oil in pellets significantly reduced the n-6/n-3 ratio and 17:0
percentage (p < 0.05; Table 2) in comparison with the control pellets. However, oil supplementation
did not result in any significant differences in the other FA compositions, PUFA contents and total
lipid content of heart tissues.
Lamb breed significantly affected some FA compositions (p < 0.05; Table 2). Purebred Merinos
had higher 17:0 (1.1 g/100 g FA) and total MUFA (26.7 g/100 g FA) compositions than W × C lambs
(0.9 g/100 g FA and 23.8 g/100 g FA respectively). In contrast, the DPA and total n-6 PUFA percentages
of W × C lambs were higher than those of M × M. There were no significant differences in PUFA
contents and total lipid content of heart among the breeds.
Significant interactions between oil addition and lamb breed on some heart FA compositions
and PUFA/SFA ratio were detected (Figure 1). First-cross W × C lambs recorded the highest DPA
composition (1.7 g/100 g FA) when they were fed pellets containing 5% flaxseed oil, while the lowest
DPA composition was observed in M×M lambs fed 2.5% canola oil pellets (0.8 g/100 g FA) (Figure 1a).
Furthermore, M×M lambs fed 2.5% canola oil pellets had higher total SFA composition than crossbred
lambs offered the same pellets (Figure 1b), and contained lower total PUFA than crossbred lambs fed
the same pellets and M×M and W× C lambs offered 5% flaxseed oil pellets (Figure 1c). Consequently,
the PUFA/SFA ratio of M ×M lambs fed pellets containing 2.5% canola oil was significantly lower
than that of crossbred lambs fed the same pellets, and M ×M lambs fed 5% flaxseed pellets (Figure 1d).
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Figure 1. Interaction effects on: (a) docosapentaenoic acid, (b) total SFA, (c) total PUFA compositions
and (d) PUFA/SFA ratio of la b hearts (M × : Merino × Merino; C × M: Corriedale × Merino;
W × C: White Suffolk × Corriedale).
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Table 2. Effects of omega–3 oil supplementation and breed on heart fatty acid profile of prime lambs.
Item 1
Treatment Breed 2 SEM 3 p Value 4
Control 2.5C 5C 2.5F 5F M×M C×M W× C T B T× B
Total lipid (g fat/100 g wet tissue) 2.6 2.7 2.8 2.9 2.4 2.8 2.7 2.5 0.09 0.35 0.23 0.16
Percentage (g/100 g total FA)
14:0 0.6 0.6 0.8 0.6 0.5 0.6 0.7 0.5 0.05 0.68 0.33 0.24
15:0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.01 0.36 0.94 0.30
16:0 12.9 12.5 13.1 12.9 12.7 12.9 12.9 12.7 0.22 0.93 0.63 0.06
17:0 1.1 a 1.0 a,b 1.0 a,b 0.9 a,b 0.8 b 1.1 a 1.0 a,b 0.9 b 0.03 0.04 0.02 0.07
18:2n-6 23.8 21.0 21.0 21.9 22.4 20.9 23.1 22.9 0.48 0.11 0.06 0.07
18:3n-3 2.0 1.8 2.5 2.1 2.7 2.5 2.1 1.7 0.18 0.53 0.24 0.56
18:1n-9 13.4 15.5 15.6 14.2 12.8 14.9 14.7 12.9 0.45 0.17 0.08 0.39
18:0 17.2 18.4 18.4 17.9 17.5 18.3 17.3 17.6 0.27 0.35 0.12 0.06
20:4n-6 (ARA) 5.6 6.2 4.3 5.8 5.2 5.1 4.8 6.5 0.33 0.33 0.06 0.06
20:5n-3 (EPA) 1.2 1.3 1.2 1.3 1.4 1.2 1.3 1.3 0.04 0.35 0.33 0.07
20:3n-6 0.5 0.4 0.4 0.4 0.5 0.4 0.4 0.5 0.01 0.22 0.37 0.44
20:4n-3 1.4 1.4 1.5 1.6 1.7 1.4 1.5 1.6 0.06 0.65 0.47 0.49
20:2n-6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.01 0.81 0.77 0.91
20:0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.01 0.99 0.74 0.87
22:5n-6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.01 0.25 0.23 0.23
22:6n-3 (DHA) 0.6 0.7 0.7 0.7 0.7 0.7 0.6 0.7 0.03 0.85 0.56 0.72
22:4n-6 0.2 0.2 0.1 0.2 0.2 0.1 0.1 0.2 0.01 0.72 0.20 0.57
22:5n-3 (DPA) 1.1 1.1 1.2 1.3 1.4 1.2 b 1.3 a,b 1.4 a 0.05 0.19 0.04 0.02
22:0 0.3 0.3 0.2 0.3 0.3 0.3 0.3 0.3 0.01 0.74 0.22 0.83
23:0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.01 0.37 0.56 0.74
24:0 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.01 0.85 0.46 0.67
∑SFA 34.5 35.1 35.9 35.2 34.2 35.5 34.5 34.8 0.46 0.63 0.31 0.01
∑MUFA 24.3 26.3 27.3 25.3 24.8 26.7 a 25.5 a,b 23.8 b 0.50 0.27 0.04 0.30
∑PUFA 41.2 38.6 36.8 39.5 41.0 37.8 40.0 41.4 0.87 0.30 0.08 0.03
PUFA/SFA 1.2 1.2 1.0 1.2 1.2 1.1 1.2 1.2 0.04 0.52 0.06 0.01
∑n-3 PUFA 6.5 6.4 6.9 6.6 7.9 7.0 6.7 6.7 0.25 0.36 0.90 0.26
∑n-6 PUFA 30.3 28.1 26.1 28.6 28.5 26.9b 28.7 a,b 30.3 a 0.68 0.17 0.02 0.06
n-6/n-3 4.8 a 4.4 a,b 4.1 a,b 4.3 a,b 3.6 b 4.0 4.4 4.6 0.15 0.02 0.28 0.83
Content (mg/100 g wet tissue)
18:3n-3 24.1 26.7 24.6 27.5 31.0 31.7 18.7 26.7 2.19 0.83 0.09 0.81
20:4n-6 77.1 101.7 59.9 68.8 71.0 68.6 60.4 99.0 7.44 0.55 0.08 0.58
EPA 13.7 15.7 15.4 18 20.5 16.1 13.1 20.3 1.37 0.64 0.07 0.56
22:5n-6 1.1 1.1 1.2 1.1 0.9 1.0 1.0 1.3 0.09 0.89 0.23 0.94
DHA 7.8 8.0 8.1 9.3 10.4 9.2 6.4 10.1 0.71 0.79 0.14 0.90
DPA 14.0 15.3 16.1 18.0 20.0 15.3 13.4 20.6 1.37 0.72 0.07 0.58
EPA + DHA 21.5 23.7 23.5 27.3 30.9 25.3 19.5 30.4 2.02 0.67 0.09 0.72
EPA + DHA + DPA 35.5 39.0 39.6 45.3 50.9 40.6 32.9 51.0 3.36 0.69 0.08 0.66
1 All definitions and abbreviations are as indicated in Table 1; FA: fatty acid; ARA: arachidonic acid; EPA: eicosapentaenoic acid; DPA: docosapentaenoic acid and DHA: docosahexaenoic
acid; 2 M ×M: purebred Merino; C ×M: Corriedale and Merino crossbred; W × C: White Suffolk and Corriedale crossbred; 3 SEM: standard error of the mean; 4 T: treatment; B: breed; T
× B: treatment × breed. Row means bearing different superscripts within a fixed factor differ significantly (p < 0.05). In all lamb tissues (Tables 2–4), low levels of trans 18:1 isomers and
conjugated linoleic acid (CLA) isomers were also present.
Nutrients 2017, 9, 893 8 of 17
3.3. Liver Fatty Acid Profile
The lambs fed pellets containing 5% flaxseed oil had significantly higher liver DHA (3.4 g/100 g
FA) and total n-3 PUFA (11.5 g/100 g FA) percentages (p < 0.05; Table 3) than the lambs offered the
control pellets (2.4 g/100 g FA and 9.2 g/100 g FA respectively). The inclusion of 5% flaxseed oil in
pellets also reduced 16:0 and 17:0 compositions, and n-6/n-3 ratio in lamb livers compared to the control
pellets. It was apparent that the livers contained high levels of EPA + DHA (148.1–206.9 mg/100 g wet
tissue) and total n-3 LC-PUFA (270.5–379.8 mg/100 g wet tissue). However, these contents were not
influenced by oil supplementation. Lamb breed did not affect the total lipid percentage and FA profile
of liver. There were no significant interactions between oil inclusion and lamb breed on liver total lipid
percentage and FA profiles.
3.4. Kidney Fatty Acid Profile
Supplementing flaxseed oil in the pellets resulted in increases in the EPA and DPA compositions
of lamb kidney compared to the control pellets (p < 0.05; Table 4). Furthermore, the kidneys of lambs
fed pellets containing flaxseed oil were higher in total n-3 PUFA composition than those of lambs from
the control and 2.5% canola oil groups. The n-6/n-3 ratio in kidneys significantly reduced for lambs
offered flaxseed oil pellets. Oil supplementation significantly reduced the 17:0 composition of lamb
kidney. The incorporation of 5% both canola and flaxseed oils in the pellets reduced 22:5n-6 content,
while there were not significant differences in other PUFA contents including EPA + DHA and total
n-3 LC-PUFA.
It was observed that lamb breed influenced variations in some kidney fatty acids (p < 0.05).
First-cross W × C lambs recorded the highest 20:4n-6 (14.2 g/100 g FA) and DPA (3.2 g/100 g FA)
compositions. However, they had lower 17:0 and DHA percentages in liver than M × M and C ×
M lambs. The livers contained more than 60 mg of EPA + DHA and 100 mg of total n-3 LC-PUFA
in 100 g wet tissue (Table 4). The DHA and EPA + DHA contents of M ×M liver were higher than
those of C ×M liver. There were no significant differences in kidney total lipid percentage among the
breeds. Significant interactions between oil inclusion and lamb breed on the total lipid percentage and
FA profiles of kidney were not observed. Liver and kidney of prime lambs had high contents of EPA
+ DHA and total n-3 LC-PUFA. These visceral organs can be classified as good sources of omega–3.
A marked decrease in n-6/n-3 ratio of the investigated organs was observed when 5% flaxseed oil was
added to the diet of finishing lambs. Supplementing 5% flaxseed oil also increased the DHA and total
n-3 PUFA compositions of liver. Addition of flaxseed oil resulted in increases in the EPA, DPA and
total n-3 PUFA compositions of kidney. First-cross W × C lambs had higher DPA compositions of
heart and kidney than M ×M. Lamb breed affected the DHA and EPA + DHA contents of kidney and
plasma glucose concentration. Significant interactions between oil addition and lamb breed on heart
FA compositions and plasma glucose concentration were observed.
3.5. Plasma Metabolites
Plasma metabolite concentrations of the experimental lambs are presented in Table 5. The glucose
concentration of W × C lambs (4.5 mmol/L) was significantly higher (p < 0.05) than that of MxM
lambs (4.0 mmol/L). Moreover, there was a significant interaction between oil supplementation and
lamb breed on glucose concentration. First-cross W × C lambs fed pellets containing 2.5% canola
oil had higher glucose concentration than M ×M lambs fed the control and 2.5% canola oil pellets
(Figure 2). Oil supplementation did not cause significant alteration in lamb plasma metabolites.
However, the lamb urea concentration exceeded its normal ranges. No significant differences in
plasma metabolite profiles between supplemented and control lambs imply that there were no obvious
health disadvantages to the lambs as a result of oil inclusion.
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Table 3. Liver fatty acid profile of prime lambs as influenced by omega–3 oil supplementation and breed.
Item 1
Treatment Breed
SEM
p Value
Control 2.5C 5C 2.5F 5F M×M C×M W× C T B T× B
Total lipid (g fat/100 g wet tissue) 6.3 6.6 6.2 6.3 6.4 6.4 6.6 6.0 0.16 0.99 0.37 0.74
Percentage (g/100 g total FA) 2
14:0 0.5 0.4 0.4 0.4 0.4 0.4 0.5 0.4 0.02 0.44 0.22 0.22
15:0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.01 0.22 0.12 0.59
16:0 18.0 a 17.4 a,b 17.4 a,b 17.3 a,b 15.9 b 17.2 17.3 17.2 0.28 0.03 0.85 0.47
17:0 1.4 a 1.3 a,b 1.3 ab 1.3 a,b 1.2 b 1.4 1.3 1.3 0.03 0.02 0.24 0.56
18:2n-6 10.5 10.0 10.1 9.7 10.0 10.5 9.7 10.1 0.20 0.68 0.35 0.59
18:3n-3 2.0 2.3 2.5 2.5 2.7 2.4 2.5 2.1 0.10 0.17 0.53 0.66
18:1n-9 20.7 20.5 20.7 18.1 18.8 19.9 20.2 19.6 0.44 0.30 0.88 0.61
18:0 18.9 19.6 19.3 21.7 20.4 19.4 19.9 20.2 0.41 0.17 0.70 0.36
20:4n-6 (ARA) 4.2 4.6 3.1 4.4 4.5 3.7 4.7 4.0 0.33 0.73 0.57 0.77
20:5n-3 (EPA) 1.3 1.4 1.3 1.3 1.6 1.3 1.5 1.3 0.06 0.68 0.51 0.27
20:3n-6 0.7 0.7 0.7 0.6 0.6 0.7 0.7 0.7 0.03 0.50 0.86 0.07
20:4n-3 0.2 0.1 0.2 0.2 0.1 0.2 0.2 0.2 0.01 0.15 0.47 0.82
20:2n-6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.01 0.27 0.30 0.54
20:0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
22:5n-6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.01 0.33 0.26 0.70
22:6n-3 (DHA) 2.4 b 2.5 b 2.6 a,b 2.9 a,b 3.4 a 2.9 2.6 2.5 0.13 0.03 0.50 0.18
22:4n-6 0.5 0.4 0.4 0.4 0.3 0.4 0.4 0.5 0.02 0.26 0.32 0.66
22:5n-3 (DPA) 3.3 3.1 3.4 3.4 3.7 3.1 3.3 3.6 0.12 0.64 0.24 0.47
22:0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.01 0.62 0.99 0.92
23:0 0.4 0.4 0.4 0.3 0.3 0.4 0.4 0.4 0.01 0.71 0.83 0.21
24:0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.01 0.80 0.84 0.06
∑SFA 40.8 41.3 41.4 44.1 40.6 41.2 41.6 41.8 0.54 0.23 0.90 0.12
∑MUFA 32.6 32.0 33.1 29.2 31.1 32.1 31.5 31.6 0.54 0.29 0.91 0.68
∑PUFA 26.6 26.7 25.5 26.7 28.3 26.7 26.9 26.6 0.59 0.92 0.98 0.47
PUFA/SFA 0.7 0.6 0.6 0.6 0.7 0.6 0.6 0.6 0.07 0.69 0.74 0.21
∑n-3 PUFA 9.2 b 9.6 a,b 9.7 a,b 10.3 a,b 11.5 a 9.9 10.0 9.7 0.32 0.04 0.99 0.26
∑n-6 PUFA 16.5 16.3 14.8 15.6 15.9 15.9 16.0 15.9 0.40 0.73 0.96 0.67
n-6/n-3 1.8 a 1.7 a,b 1.6 a,b 1.6 a,b 1.4 b 1.6 1.7 1.7 0.05 0.03 0.96 0.57
Content (mg/100 g wet tissue)
18:3n-3 79.3 86.7 115.7 111.7 118.9 107.9 99.6 88.2 7.20 0.36 0.77 0.57
20:4n-6 186.0 176.6 135.6 225.2 202.5 177.0 192.6 184.2 19.89 0.85 0.96 0.88
EPA 50.9 53.5 58.2 64.8 71.6 56.9 61.2 56.0 4.73 0.86 0.90 0.59
22:5n-6 9.7 9.8 9.7 7.4 8.0 10.6 7.8 8.9 0.72 0.77 0.30 0.91
DHA 97.2 99.1 108.8 142.0 146.8 128.7 110.0 106.0 9.23 0.49 0.71 0.75
DPA 131.1 118.0 156.0 167.4 161.4 140.5 138.6 153.4 11.95 0.76 0.77 0.69
EPA + DHA 148.1 152.5 167.0 206.9 218.3 185.6 171.2 162.0 13.53 0.61 0.88 0.72
EPA + DHA + DPA 279.1 270.5 323.0 374.3 379.8 326.1 309.9 315.5 24.89 0.70 0.97 0.74
1 All definitions and abbreviations are as indicated in Tables 1 and 2. FA: 2 fatty acid; Row means bearing different superscripts within a fixed factor significantly differ (p < 0.05).
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Table 4. Variation in kidney fatty acid profile of prime lambs as influenced by omega–3 oil supplementation and breed.
Item 1
Treatment Breed
SEM
p Value
Control 2.5C 5C 2.5F 5F M×M C×M W× C T B T× B
Total lipid (g fat/100 g wet tissue) 3.0 3.1 2.8 3.0 2.9 3.0 3.0 3.0 0.05 0.53 0.65 0.42
Percentage (g/100 g total FA)2
14:0 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.02 0.44 0.77 0.65
15:0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.01 0.68 0.58 0.68
16:0 17.0 17.2 16.5 16.4 16.0 16.6 17.0 16.3 0.19 0.53 0.47 0.94
17:0 1.2 a 1.1 b 1.1 b 1.0 b,c 0.9 c 1.1 a 1.1a 1.0b 0.02 0.00 0.02 0.07
18:2n-6 12.7 12.6 12.5 12.7 12.6 12.6 12.4 12.8 0.17 0.93 0.84 0.90
18:3n-3 1.1 1.1 1.2 1.2 1.5 1.2 1.3 1.1 0.06 0.22 0.49 0.11
18:1n-9 11.9 12.7 11.7 11.3 11.6 12.1 12.4 11.1 0.25 0.52 0.12 0.51
18:0 17.4 17.5 17.9 17.5 17.8 17.7 17.0 18.1 0.18 0.89 0.16 0.96
20:4n-6 13.8 13.7 13.2 12.7 12.1 12.5 b 13.1 a,b 14.2 a 0.29 0.27 0.04 0.69
20:5n-3 (EPA) 1.9 b 2.0 b 2.3 a,b 2.5 a 2.8 a 2.3 2.0 2.3 0.09 0.01 0.08 0.80
20:3n-6 0.9 0.8 0.8 0.9 0.8 0.8 0.8 0.9 0.03 0.86 0.11 0.72
20:4n-3 0.6 0.7 0.7 0.7 0.7 0.7 0.6 0.6 0.02 0.63 0.17 0.71
20:2n-6 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.01 0.91 0.65 0.27
20:0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.01 0.30 0.29 0.32
22:5n-6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.01 0.65 0.79 0.85
22:6n-3 (DHA) 2.3 2.3 2.4 2.4 2.4 2.5 a 2.4 a 2.1 b 0.07 0.88 0.03 0.11
22:4n-6 0.4 a 0.4 a 0.3 a,b 0.3 a,b 0.2 b 0.3 0.4 0.4 0.02 0.04 0.14 0.88
22:5n-3 (DPA) 2.7 b 2.8 a,b 3.1 a,b 3.2 a 3.3 a 2.8 b 2.9 b 3.2 a 0.07 0.04 0.05 0.29
22:0 1.2 1.2 1.1 1.1 1.1 1.1 1.1 1.2 0.04 0.85 0.33 0.93
23:0 0.4 0.4 0.4 0.3 0.3 0.4 0.3 0.3 0.01 0.48 0.09 0.30
24:0 1.4 1.3 1.3 1.2 1.2 1.3 1.2 1.4 0.05 0.77 0.22 0.99
∑SFA 40.5 40.5 40.0 39.4 39.6 40.4 39.7 40.3 0.26 0.70 0.64 0.94
∑MUFA 21.1 21.4 20.5 21.7 22.0 21.5 22.6 19.7 0.43 0.88 0.06 0.97
∑PUFA 38.4 38.1 39.5 38.9 38.4 38.1 37.7 40.0 0.40 0.87 0.10 0.79
PUFA/SFA 0.9 0.9 1.0 1.0 1.0 0.9 0.9 1.0 0.01 0.93 0.45 0.82
∑n-3 PUFA 8.7 b 8.8 b 9.8 a,b 10.0 a 10.3 a 9.5 8.8 9.7 0.19 0.01 0.06 0.70
∑n-6 PUFA 28.2 27.5 28.0 27.1 26.1 26.7 27.1 28.7 0.38 0.49 0.22 0.86
n-6/n-3 3.3 a 3.2 a,b 2.9 a,b,c 2.7 b,c 2.5 c 2.8 3.1 3.0 0.08 0.02 0.39 0.92
Content (mg/100 g wet tissue)
18:3n-3 18.6 19.7 19.9 23.6 24.6 22.0 22.5 18.6 1.72 0.78 0.63 0.18
20:4n-6 243.6 245.0 223.2 204.3 202.7 234.5 207.0 239.6 9.35 0.46 0.66 0.48
EPA 33.7 37.6 38.1 41.7 45.5 43.0 32.3 39.9 2.00 0.39 0.17 0.86
22:5n-6 2.2 a 2.2 a 1.3 b 1.5 a,b 1.2 b 1.8 1.6 1.9 0.13 0.02 0.82 0.67
DHA 39.2 39.2 39.3 40.5 42.1 46.5 a 33.0 b 40.9 a,b 1.87 0.98 0.05 0.28
DPA 50.3 49.7 50.6 51.1 51.3 52.7 45.5 53.5 1.93 0.92 0.44 0.35
EPA + DHA 72.9 76.8 77.4 82.2 87.6 89.5 a 65.3 b 80.8 a,b 3.45 0.87 0.05 0.70
EPA + DHA + DPA 123.2 126.5 128.0 133.3 138.9 142.2 110.8 134.3 5.14 0.96 0.16 0.56
1 All definitions and abbreviations are as indicated in Tables 1 and 2. 2 FA: fatty acid; Row means bearing different superscripts within a fixed factor significantly differ (p < 0.05).
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Table 5. Influence of omega–3 oil supplementation and breed on plasma metabolite profiles of prime
lambs (mmol/L).
Item 1
Treatment Breed
SEM Normal
Range
p Value
Control 2.5C 5C 2.5F 5F M×M C×M W× C T B T× B
Cholesterol 1.3 1.5 1.5 1.4 1.2 1.3 1.4 1.4 0.04 1.1–1.5 0.13 0.62 0.92
Urea 7.8 7.7 7.5 7.6 7.5 7.8 7.4 7.3 0.16 2.8−7.2 0.27 0.44 0.93
Calcium 2.6 2.6 2.7 2.6 2.7 2.7 2.7 2.6 0.02 2.4−3.2 0.26 0.15 0.61
Magnesium 1.1 1.0 1.0 1.0 1.0 1.0 1.0 1.1 0.02 0.8−1.2 0.83 0.64 0.62
BHB 0.3 0.3 0.4 0.3 0.4 0.3 0.4 0.3 0.02 0.0−0.8 0.66 0.85 0.95
Glucose 4.2 4.5 4.3 4.1 4.2 4.0 b 4.3 a,b 4.5 a 0.07 2.8−4.5 0.48 0.03 0.04
1 As indicated in Table 2; BHB: Beta–hydroxybutyrate. Row means bearing different superscripts within a fixed
factor significantly differ (p < 0.05).
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Figure 2. Variations in plasma glucose concentration as influenced by oil supplementation and breed
interaction (M×M: Merino×Merino; C×M: Corriedale×Merino; W×C: White Suffolk×Corriedale).
4. Discussion
In Australia and New Zealand, food can be classified as a ‘source’ of n-3 PUFA if it contains at
least 30 mg of EPA + DHA per standard serve and can be a ‘good source’ if it contains no less than
60 mg of EPA + DHA per standard serve [31]. A standard serve of red meat for Australian adults is
reported to be 135 g [32,33]. Our study has demonstrated that hearts from lambs fed oil supplemented
pellets could be a source of n-3 PUFA, although oil supplementation did not significantly influence EPA
+ DHA content. Furthermore, lamb kidneys and livers could be labelled as good sources of n-3 PUFA.
Our research is in agreement with other studies that have assessed FA profile of edible by-products
from lamb [27] and goat [20] and have reported that the total n-3 LC-PUFA content of liver and kidney
were higher than that of heart.
The main traditional source of n-3 CL-PUFA is seafood including fish, crustaceans and molluscs,
however, different types of seafood contain widely different amounts of n-3 LC-PUFA [34]. In a
typical seafood serve size (150 g raw), white-fleshed Australian wild-caught fish contain approximately
350 mg n-3 CL-PUFA (233 mg/100 g raw), while shellfish and prawns have about 225 (150 mg/100 g
raw) and 180 mg (120 mg/100 g raw) respectively [34]. Omega-3 LC-PUFA content of liver in the
present study was generally higher than that of white-fleshed Australian wild fish. Furthermore,
the contents of n-3 LC-PUFA in lamb kidney and prawns were similar. Thus, liver and kidney may be
considered as alternative and ‘good sources’ of n-3 LC-PUFA.
Several epidemiological studies have demonstrated that consumption of the less studied n-3
LC-PUFA - DPA - is positively correlated with lower incidence of coronary heart diseases and
platelet aggregation [35,36], improvement in lipid metabolism, and inhibition of inflammation [37].
Furthermore, Byelashov et al. [35] stated that DPA improves cognitive function and mental health.
Red meat contains relatively high levels of DPA compared to fish [38] and plays a major part in many
diets [39,40]. In the present study, it is evident that the content of DPA in heart, kidney and liver
was higher than those of EPA and DHA. Howe et al. [41] stated that DPA contributes approximately
30% of total n-3 LC-PUFA in Australian diets. Therefore, it is being increasingly discussed that DPA
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should be included in total n-3 LC-PUFA intake [35,41,42]. In fact, the Australian and New Zealand
governments have offered guidelines for DPA intake along with EPA and DHA [43]. Including DPA
in n-3 LC-PUFA intake would boost the total n-3 LC-PUFA content of lamb to higher values [29,38]
which is in agreement with our findings.
It is now widely accepted that lipid supplementation of ruminant diets is an effective approach to
modify edible fats. Feeding canola oil or flaxseed oil is a straightforward way to increase n-3 LC-PUFA
in ruminant meat [44]. Nguyen et al. [45] also concluded that supplementing 5% of these oils (via
supplementation) in prime lamb diets increased n-3 LC-PUFA contents of Longissimus muscle. Indeed,
the inclusion of 5% flaxseed oil in this study increased the relative composition and content of liver
DHA and kidney DPA, and total n-3 PUFA compositions in both liver and kidney in comparison
with the control diet. These increases could be due to the increase in the intake and the ruminal
concentration of ALA increased in diet [5,45]. Dietary ALA is an important n-3 PUFA that is used as a
precursor for the production of tissue n-3 LC-PUFA including EPA, DPA and DHA. Research has shown
that ruminant n-3 LC-PUFA composition can be improved by increased dietary ALA intake from
ALA-abundant vegetable oils [9,46]. Our findings are in agreement with Adeyemi et al. [5] who found
significant increases in the EPA and total n-3 PUFA compositions of liver when supplementing up to 8%
with a blend of 80% canola oil and 20% palm oil in goat diets. Similarly, Kashani et al. [47] investigated
the FA compositions of different tissues in dual-purpose Australian lambs and concluded that liver
EPA and total n-3 PUFA compositions were significantly influenced by Spirulina supplementation.
Kim et al. [22] and Demirel et al. [48] also reported the n-3 LC-PUFA compositions of lamb liver
increased when dietary ALA intake was increased. Therefore, our results in combination with previous
studies indicate that tissue n-3 LC-PUFA compositions are influenced by the level of dietary ALA intake.
Ruminant FA profiles are also directly associated with the extensive biohydrogenation of dietary
MUFA and PUFA conducted by ruminal microbes. In the rumen, ALA is hydrogenated to rumelenic
acid (cis-9, trans-11, cis-15 18:3) and subsequent reduction via rumenic acid (cis-9, trans-11 18:2), then
to vaccenic acid (trans-11 18:1) and finally to stearic acid (18:0) [49] with an extent of 85–100% [50].
Furthermore, Doreau and Ferlay [50] stated that lipid digestibility in the small intestine is independent
of the level of FA intake. This could explain the absence of significant oil supplementation effects on
the n-3 LC-PUFA contents of heart, liver and kidney in our study.
Our findings indicated that variations in the FA profiles of editable organs were influenced
by lamb breed, a finding that can be summarised as the individual n-3 LC-PUFA compositions of
heart and kidney differed between M ×M and W × C lambs. These variations could be explained
by differences occurring in fatty acid metabolism, lipogenesis and deposition arising from genetic
variation, as indicated by previous studies [18,51]. This interpretation is supported by Sanudo et al. [52]
who found Merino lambs had lower EPA and DPA compositions than coarse wool breeds. In contrast,
Hoffman et al. [53] did not observe differences in the EPA and DPA compositions of cooked heart, liver
and kidney between Merino and Dorper lambs. The possible explanation for the observed differences
between our study and that of Hoffman et al. [53] is the status of investigated tissues. Tissue FA profiles
could be changed during cooking [54,55]. In the present study, lamb breed did not affect total n-3
PUFA compositions and n-3 LC-PUFA contents, consistent with the report of Malau-Aduli et al. [27].
Various studies stated that the effects of variations in n-3 LC-PUFA due to lamb breed were much more
complicated and of a lower magnitude than variations due to the nutritional background [27,32,56].
The results of our study found no significant effect of supplementing enriched omega–3 oils on
plasma cholesterol concentration in contrast to Obeidat et al. [57] and Bhatt et al. [58] who concluded
that increases in cholesterol occurred. The variations in forms and higher dosages of fat sources used
in these previous studies could explain the observed differences. Various studies reported that lipid
supplementation did not influence the glucose and urea concentrations of ruminant plasma [59–61].
In agreement with these studies, our results showed that the inclusion of canola oil or flaxseed oil did
not significantly alter the plasma concentrations of glucose and urea. An explanation for the absence
of significant differences in plasma metabolite concentrations could be related to the similarity of
Nutrients 2017, 9, 893 13 of 17
metabolisable energy components among the diets used in our study. Second, the oil levels used in
this study were at or below 50 g/kg dry matter intake (DMI) to avoid the possibility of negative effects
on DMI and nutrient digestibility [62].
In agreement with our results, Malau-Aduli and Holman [63] and Malau-Aduli et al. [64] found
that differences in plasma glucose among lamb breeds were observed. In beef cattle, Stahlhut et al. [65]
also reported Angus cows had higher plasma glucose concentrations than Simmental cows and
concluded that plasma glucose concentration was influenced by average daily gain, milk production
and FA profile of carcass. Differences in average daily gain [66] and FA profile [27,55] have been
reported between purebred Merino and crossbred lambs, indicating a potential for differences in
plasma glucose concentration between the breeds. The high concentration of plasma urea in the
present study could be due to high crude protein levels in the diets. Butler [67] and Sunny et al. [68]
stated that the high dietary intake of protein and the balance of protein fractions present in the rumen
can result in increased blood concentrations of urea.
Potential Human Health Implications for Consumption of Lamb Liver and Kidney
Nguyen et al. [45] reported the nutritional value, lipid percentage, fatty acid profile and sensory
characteristics of visceral adipose and muscle tissues in these same 60 lambs used in the present study.
They demonstrated that a standard serve (135 g) of meat produced from lambs supplemented with 5%
oil contained more than 30 mg of EPA + DHA, reached the claimable ‘source’ level of n-3 LC-PUFA
and significantly affected meat tenderness, juiciness and overall liking by human meat consumers.
The finding in the current study that lamb liver and kidney also reached the claimable ‘source’ level of
n-3 LC-PUFA has potential human health implications from the viewpoint of their EPA, DHA and
DPA contents. In the n-3 synthesis pathway, DPA is an intermediary between EPA and DHA [69].
Many epidemiological studies in humans have demonstrated that DPA consumption is positively
correlated with lower incidence of coronary heart diseases and lower platelet aggregation [36,70],
and in hamsters, inhibition of inflammation and improvement in lipid metabolism [37]. Furthermore,
Lim et al. [71] stated that DPA improves mental health and spinal cord injury in mice, but the roles
of DPA in human health have been largely ignored, perhaps because it is a negligible component of
commercial fish and oil products compared to EPA and DHA n-3 LC-PUFA [35,43]. DPA contributes
approximately 30% of total n-3 LC-PUFA in human diets [41]. It can serve as a reservoir for EPA and
DHA because it is either retro-converted to EPA or elongated to DHA [72,73]. Thus, some reports
have suggested that DPA should be included in LC-PUFA intake [41,42]. Indeed, Australia and New
Zealand have offered guidelines for DPA intake along with EPA and DHA [43]. Including DPA in
n-3 LC-PUFA intake would boost the total n-3 LC-PUFA content produced in lamb meat to higher
values [29].
5. Conclusions
The results clearly demonstrated that both canola and flaxseed oils can be effectively used in
feedlot regimes in the prime lamb industry without any detrimental health effects. For prime lamb
producers wanting to achieve better product quality, in terms of FA composition, during the 10-week
intensive finishing phase, supplementing 5% flaxseed oil into the animal diets considerably improves
the content of the health benefitting n-3 LC-PUFA in the edible visceral organs. On the basis of the
favourable FA content findings presented, lamb liver and kidney could be consumed as alternative
‘good sources’ of n-3 LC-PUFA.
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